Lexaria Bioscience Corp.: Lexaria's Hormone Study Shows Significant Enhancement in Oral Estradiol Delivery
900% and 2,000% improvements in peak bloodstream delivery using DehydraTECHKELOWNA, BC / ACCESSWIRE / May 18, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a
British Columbia George Jurcic Lexaria Dehydra Gewinn Nur Lexaria Bioscience Corp Lexaria Bioscience Corp View
Source: finanznachrichten.de